Relative strength index (RSI-14) for Eyegate Pharmaceuticals, Inc. (EYEG) is at 35.36.
Stock price escalated 6.42% to finalize at $0.58 throughout previous buying and selling session.
EYEG is trading -79.65% downward from the 52-week high mark and 17.24% above from the fifty two-week low mark.